These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17020433)

  • 1. Breast cancer expression profiling: the impact of microarray testing on clinical decision making.
    Modlich O; Prisack HB; Bojar H
    Expert Opin Pharmacother; 2006 Oct; 7(15):2069-78. PubMed ID: 17020433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
    Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
    Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
    Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Has the time arrived for gene expression use at the bedside?].
    D'Hondt V; Piccart M; Sotiriou C
    Bull Cancer; 2008 Mar; 95(3):336-43. PubMed ID: 18390414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular classification of breast cancer: limitations and potential.
    Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
    Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic subtypes in choosing adjuvant therapy for breast cancer.
    Zelnak AB; O'Regan RM
    Oncology (Williston Park); 2013 Mar; 27(3):204-10. PubMed ID: 23687790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray technology and its effect on breast cancer (re)classification and prediction of outcome.
    Cardoso F
    Breast Cancer Res; 2003; 5(6):303-4. PubMed ID: 14580246
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved breast cancer prognosis through the combination of clinical and genetic markers.
    Sun Y; Goodison S; Li J; Liu L; Farmerie W
    Bioinformatics; 2007 Jan; 23(1):30-7. PubMed ID: 17130137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
    Weigelt B; Baehner FL; Reis-Filho JS
    J Pathol; 2010 Jan; 220(2):263-80. PubMed ID: 19927298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of expression profiling on prognostic and predictive testing in breast cancer.
    Reis-Filho JS; Westbury C; Pierga JY
    J Clin Pathol; 2006 Mar; 59(3):225-31. PubMed ID: 16505270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer prognostic classification in the molecular era: the role of histological grade.
    Rakha EA; Reis-Filho JS; Baehner F; Dabbs DJ; Decker T; Eusebi V; Fox SB; Ichihara S; Jacquemier J; Lakhani SR; Palacios J; Richardson AL; Schnitt SJ; Schmitt FC; Tan PH; Tse GM; Badve S; Ellis IO
    Breast Cancer Res; 2010; 12(4):207. PubMed ID: 20804570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.
    El Hage Chehade H; Wazir U; Mokbel K; Kasem A; Mokbel K
    Am J Surg; 2018 Jan; 215(1):171-178. PubMed ID: 28622841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
    Abd El-Rehim DM; Ball G; Pinder SE; Rakha E; Paish C; Robertson JF; Macmillan D; Blamey RW; Ellis IO
    Int J Cancer; 2005 Sep; 116(3):340-50. PubMed ID: 15818618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling assays in breast cancer: are we ready for prime time?
    Gökmen-Polar Y; Badve S
    Oncology (Williston Park); 2012 Apr; 26(4):350-7, 361. PubMed ID: 22655528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of breast cancer.
    Cheang MC; van de Rijn M; Nielsen TO
    Annu Rev Pathol; 2008; 3():67-97. PubMed ID: 18039137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
    Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.